Nikesh N. Shah

Oncology
3140 S Falkenburg Rd Ste 301
Riverview, FL 33578

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

A Real-World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma.

A Real-World Study Characterizing a US Population of Patients Receiving Rituximab With Gemcitabine and Oxaliplatin for Relapsed or Refractory Large B-Cell Lymphoma.

Journal: EJHaem
Published: January 26, 2026

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 02, 2025

Targeted Therapies and Immunotherapies for Diffuse Large B-Cell Lymphoma.

Targeted Therapies and Immunotherapies for Diffuse Large B-Cell Lymphoma.

Journal: Cancers
Published: June 26, 2025

Babesiosis-Induced Hemophagocytic Lymphohistiocytosis Following Spontaneous Splenic Rupture in a Florida Resident: A Case Report.

Babesiosis-Induced Hemophagocytic Lymphohistiocytosis Following Spontaneous Splenic Rupture in a Florida Resident: A Case Report.

Journal: Cureus
Published: May 02, 2025

National Cancer Grid initiative for electronic medical records, India.

National Cancer Grid initiative for electronic medical records, India.

Journal: Bulletin of the World Health Organization
Published: July 01, 2024

A comprehensive case study on successful multimodal therapy in philadelphia chromosome-positive acute myeloid leukemia with NPM1 and IDH2 mutations.

A comprehensive case study on successful multimodal therapy in philadelphia chromosome-positive acute myeloid leukemia with NPM1 and IDH2 mutations.

Journal: Leukemia research reports
Published: February 22, 2024

Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.

Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.

Journal: Leukemia & lymphoma
Published: October 27, 2022

Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform.

Forming the Hematology-Oncology Collaborative Videoconferencing (CO-VID) Learning Initiative: Experiential Lessons Learned From a Novel Trainee-Led Multidisciplinary Virtual Learning Platform.

Journal: JCO oncology practice
Published: July 09, 2021

Targeting CD22 for the Treatment of B-Cell Malignancies.

Targeting CD22 for the Treatment of B-Cell Malignancies.

Journal: ImmunoTargets and therapy
Published: May 17, 2021

Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.

Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia
Published: December 21, 2018

Radiation therapy at end of life in children.

Radiation therapy at end of life in children.

Journal: Journal of palliative medicine
Published: September 13, 2014

Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer.

Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer.

Journal: Clinical breast cancer
Published: April 22, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026